Top Story
Antibiotics that kill hospital and community-acquired infections
PharmaAsia, 8/31/2010Detailed pictures are published showing how an experimental antibiotic can kill bacteria already resistant to existing treatments. The findings could ultimately help scientists to develop new antibiotics to tackle the ...
[Full story | More stories]
Recent stories
Latest News
Vectura and GlaxoSmithKline sign licensing agreement
PharmaAsia, 9/2/2010Can Telaprevir reduce treatment duration, side-effects and cost?
PharmaAsia, 9/2/2010Low interest in antibacterials
PharmaAsia, 9/1/2010US FDA approves Taxotere injection concentrate formulation
PharmaAsia, 9/1/2010Reporter vectors to simplify miRNA target validation
PharmaAsia, 8/31/2010Treating hearing loss and balance disorders
PharmaAsia, 8/30/2010Depomed licenses Glumetza data and Acuform technology
PharmaAsia, 8/30/2010
Science
Can Telaprevir reduce treatment duration, side-effects and cost?
PharmaAsia, 9/2/2010US FDA approves Taxotere injection concentrate formulation
PharmaAsia, 9/1/2010Reporter vectors to simplify miRNA target validation
PharmaAsia, 8/31/2010Phase three trial to evaluate ARQ 197
PharmaAsia, 8/26/2010Carfilzomib could be new treatment for relapsed myeloma patients
PharmaAsia, 8/25/2010[More]
Business
Vectura and GlaxoSmithKline sign licensing agreement
PharmaAsia, 9/2/2010Low interest in antibacterials
PharmaAsia, 9/1/2010Treating hearing loss and balance disorders
PharmaAsia, 8/30/2010Depomed licenses Glumetza data and Acuform technology
PharmaAsia, 8/30/2010Seattle expands ADC collaboration with Genentech
PharmaAsia, 8/26/2010[More]
New Products
Solution to improve supply chain integrity
PharmaAsia, 8/7/2010Patent analysis software advances freedom-to-operate
PharmaAsia, 8/6/2010T-rex: refractive index detection instrument
PharmaAsia, 7/22/2010Quant test to help chronic myeloid leukemia patients
PharmaAsia, 7/21/2010Screening plates identify optimum scavengers
PharmaAsia, 7/20/2010[More]
Cover Stories
Beyond the paradox of progress
PharmaAsia, 8/1/2010The Call of Asia
PharmaAsia, 6/1/2010Pushing Frontiers in High Throughput Screening (HTS)
PharmaAsia, 5/1/2010Proteomics: Resource Efficiency
PharmaAsia, 3/1/2010Digital Pathology and Biomarkers Help Pave the Way to Personalized Medicine
PharmaAsia, 1/1/2010[More]
Current Issue
Cover StoryBeyond the paradox of progress
PharmaAsia, 8/1/2010Recent scientific advances in biology and genomics have amplified the call to identify targets for anticancer therapies. Meanwhile, the cost of developing oncology drugs has increased, while the number of molecules that survive the arduous path to market has declined. In the development of molecularly ...
